Resveratrol enhances antitumour T cell immunity by promoting abnormal glycosylation and dimerization of PD-L1, preventing PD-1 interaction with the PD-L1, and, consequently, increasing the susceptibility of aggressive cancer cells to T-cell-mediated cell death. The gene discussed is CD274; the disease is cancer.